Viokace (2017-12-05)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 160229A | Viokace | - Recalling Firm
- Allergan Inc.
- 85 Enterprise Blvd, Suite 500
- Markham
- L6G 0B5
- Ontario
- CANADA
- Marketing Authorization Holder
- Aptalis Pharma Canada ULC
| Tablet | DIN 02230019 | Lipase 10,440 USP units |
Affected products
Viokace
Out of specification for enzyme profile during stability testing in affected lot.
Wholesalers and pharmacies across Canada